title: HCV-associated cryoglobulinaemic vasculitis: triple/dual antiviral treatment and/or rituximab?
authors.affiliation: Clinic of Nephrology, Internal and Occupational Diseases, First Moscow State Medical University, Moscow, Russia.
authors.forename: Tatiana
authors.initials: T
authors.lastname: Ignatova
authors.affiliation: Clinic of Nephrology, Internal and Occupational Diseases, First Moscow State Medical University, Moscow, Russia.
authors.forename: Olga
authors.initials: O
authors.lastname: Chernova
authors.affiliation: Clinic of Nephrology, Internal and Occupational Diseases, First Moscow State Medical University, Moscow, Russia.
authors.forename: Pavel
authors.initials: P
authors.lastname: Novikov
authors.affiliation: Clinic of Nephrology, Internal and Occupational Diseases, First Moscow State Medical University, Moscow, Russia.
authors.forename: Sergey
authors.initials: S
authors.lastname: Moiseev
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D003449:Cryoglobulinemia / Q000188:drug therapy*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D011480:Protease Inhibitors / Q000008:administration & dosage*; D012254:Ribavirin / Q000008:administration & dosage*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011480:Protease Inhibitors; D011092:Polyethylene Glycols; D012254:Ribavirin
keywords: DMARDs (biologic); Infections; Systemic vasculitis